Skip to main content
Fig. 7 | European Journal of Medical Research

Fig. 7

From: Grid2 interacting protein is a potential biomarker related to immune infiltration in colorectal cancer

Fig. 7

Kaplan–Meier survival curves comparing high and low expression of GRID2IP in CRC. A–C Overall Survival (OS), Disease Specific Survival (DSS), Progress Free Interval (DFI) of CRC patients with high and low expression of GRID2IP. D–I KM survival curves (OS) of high and low GRID2IP group in different clinical subgroups. There are statistically significant differences, including T-stage (T3&T4) (D), N-stage (N1&N2) (E), Pathologic stage (Stage III & Stage IV) (F), residual tumor (R1&R2) (G), lymphatic invasion (No) (H) and BMI (< 25) (I)

Back to article page

European Journal of Medical Research

ISSN: 2047-783X

Contact us